Appendix — The Toilet Goods Association, Inc. v. John w.ga Rdner, Secretary of Health, Education, and Welfare
Supreme Court brief1967
Ask Donna
What actually matters in this document.
Text
— — —U—ͤ— 6a
. —
N ‘
. 1 APPENDIX A
Unrrro Stur _— OF APPEALS
For THE SECOND *
No. 225--Beptenber Term, 1965
E
1 (Argued February. 25, 1966. Decided _ 13, .
Docket No. 30261
1 THE Tomer Goons Association, IN.; Anrra D’Focen,
N Inc.; Avon Propucts, INc.; BEAUTY CouNSELORS,
Inc.; Bonne BRL, INc.; Boursow, Inc.; CHARLES
~ OF THE Rrrz, IN.; CHESEBROUGH-PoND’s, INC.;
. Curistian Dior Perrumes Corp.; Ciamrot INcorpo-
* RATED; COLONIAL Dames Co., Lm.; Cory, Inc.; Fa-
BERGE Ixc.; - FRANCES DENNY, Ixo.; THE FULLER o
Bnusk Co.; TRR Gzorce W. ‘Ltrt Co, Ing; THE '
Poe GILLETTE Company; A. M. HANSEN, DOING BUSINESS
aS House or Hoiiywoop; HARPER MertHop, Inc.;
HELENA Rusinstun, Inc.; Hetene Cyrtis Inpus-
TRIES, Inc.; HEN: x/Haran/Hutcxines, Inc.; Hen-
BOLD LasoraTory, c.; JoHN H. BRECK,. INC. ;
— Kotmar Lasora INC.; ‘Laby ‘Lennox Com-
| PANY, Inc.; LEHN & FNR Propucts CoRPORATION ; .
: - ARNOLD * LEWIS, DOING BUSINESS 48 STUDIO Cos-
. METO Co.; Max Factor & Co.; MAYBELLINE’
_ MERLE Norman CosMETICS, Ino.; Jack B. ‘Nar
EROUTT, DOING. BUSINESS AS NETHERCUTT LABORA-
TORIES ; ‘NEUTROGENA _ Corr. ; . NUTRILITE Pnopvors,
| eee ae a,
r
— ; ne re ee ee eee
5 . . . * ? -
i 2a
1 Or 97 Company; Private LABEL. CosMETICS
Co., Inc.; _Purrran Cosmetics. Co.; Revion, Inc. ;
. Roux _Laporatories, Inc.; SHULTON, INC.; Ax D
YARDLEY OF LONDON, INC., PLAINTIFFS-APPELLEES
JoHN W. GARDNER, SECRETARY OF HEaLTH, Epvuca-
, TION, AND “WELFARE, AND JAMES L. Gopparp, Com-
MISSION ER OF Foop AND Dnvcs, DEFENDANTS-APPEL-
Before - WATERMAN, Moore re ‘FRIENDLY , Circuit
| —
APPEAL BY THE SECRETARY OF HEALTH, EDUCATION AND
WELFARE AVD THE COMMISSIONER OF FOOD AND DRUGS FROM
A ORDBR OF THE DISTRICT COURT FOR THE SOUTHERN 57s.
TRICT OF. NEW YORE, HAROLD R. TYLER, IR., JUDGE, DENYING 1
THEIR MOTIOX¥ TO DISMISS OR GRANT SUMMARY JUDGMENT IN
AN ACTION FOR A DECLARATION OF INVALIDITY OF FOUR FOOD
AND DRUG ADMINISTRATION REGULATIONS RELATING TO COLOR
ADDITIVES. AFFIRMED AS TO — 12 AND 8; —
48 TO COUNT A.
Aron S. Oki (Ronkirr M. Monanxrfab, UNITED
. States ATTORNEY For THE SouTHERN District. OF
New York; Jauss G. :GREILSHEIMER, ASSISTANT
_ Untrep ‘States ATTORNEY, OF * FOR DE-
FENDANTS-APPELLANTS
Epwarp J. Ross (BREED, Amporr 4 Mongax, ‘NEW
Tonk, N.Y.; STepHen-R. OF CounsEL), FOR
PLAINTIFFS APPELLEES 5
anger Cirouit Judge.
In July 1960, Congress added to the Federal Food,
, and Cosmetic Act a number of new provisions
; 1 as the Color Additive Amendments, 74 Stat.
397, 21 U.S.C. §§ 321-376. These were intended
2
b= 5
‘ “to authorize the use of suitable color additives
in or on foods, drugs, and cosmetics in accord-
5 regulations to be issued by the Secre-
f of Health, Education, and Welfare,
; peering the conditions, including maximum
lerance, under which such additives may be
safely. used. H. R. Rep. No. 1 86th Cong,
2d Sess, 1960. U.S. Gode Cong. & A
The Commissioner of Food and Drugs, to 3 * :
Secretary of Health, Education and Welfare has dele-
gated the Department’s functions under the Act, 22
F. Re 1051 (1957), 25 F. R. 8625 (1960), held rule-
making proceedings conforming to § 4 of the Admin-
istrative Procedure Act, 5 U.S.C. §-1003, and issued
Color Additive Regulations, 21 C. F. R. Part 8, effee-
tive, with certain exceptions, on June 22, 1963.
The following November the Toilet Goods Associa-
tion, a trade organization of cosmetic manufacturers
‘whose members allegedly represent 90% of annual
United States sales, and forty manufacturers and
distributors of cosmetics brought this action against
the Secretary and the Commissioner in the District
Court for the Southern District of New York for a
‘ declaratory judgment that four provisions of the Reg-
ulations exceeded the authority conferred by the
statute.. Jurisdiction was properly predicated on 28
U.S.C. §§ 1331 and 1337. See Smith v. Kansas City
Tittie & Trust Co, 255 U.S. 180 (1921). The'defend-
We thus do not reach the question whether 5; 10 of the Ad-
ministrative Procedure Act, 5 U.8 C. 8 1009, constitutes an
8 "| affirmative grant of jurisdiction with respect to the review of
federal administrative action, as the Supreme Court apparently
assumed in Rusk v. 1 367, 371-72 (1962). and we
recently did in Cappadora v. Cclebresse, — F. 9d —— ( a
Cir. 1966). But see Ove Gustavsson Contracting Co. v. Floete, .
278 F. 2d 912 (2 Cir.), cert. denied, 364 U.S. 894 (1960).
Simo. 28 U.S.C. §§ 1886-40 do not require jurisdictional
sas
n n
a ; é * ’ : | : : N
| A moved to dismiss or to strike certain portions
of the complaint on various grounds, among others
that the case was inappropriate for declaratory relief
and that the action was an unconsented suit against
the sovereign; plaintiffs cross-moved for summary
judgment. In November 1964 Judge Tyler denied
both motions in an opinion, 235 F. Supp. 648, relying ©
in part on Abbott Labs v. Celebrease, 228 F. Supp.
855 (D. Del. 1964), where the court had granted a
declaratory judgment invalidating labeling regula-
tions under the same statute. . A year later, when the
case was nearly ready for trial, the Secretary and
the Commissioner ‘renewed their motion to dismiss
on the two grounds stated, arguing that a different
conclusion on “the issue of justiciability was called
for by the Third Circuit’s reversal of the Abbott
Laboratories decision, 352 F. 2d 286 (1965) and the
District of Columbia Circuit’s recent holding that
declaratory relief was not availablé to challenge cer-
tain regulations adopted under the Tobacco Inspec-
tion Act, 7 U.S.C. §714(b), Danville. Tobacco Ass’n
v. Freeman, 351 F. 2d 832 (D.C. Cir. 1965). Judge
Tyler adhered to his determination but, at the de-
fendants request, made the necessary certification for
an application té prosecute an interlocutory appeal
under 28 UG. C. § 1292 (b); permission to appeal was
granted by a il of this court.
The first tw of the complaint charge that the
Regulations pres the authority conferred by the
statute in treating finished cosmetic products and all
diluents—unpigmented materials with which colors
are mixe. mixed as color additives subject to various re-
passport passport and citizenship matters, where none of these sections
is applicable and the jurisdictional amount sequined by 8 1331 is
not met. :
* Subsequent to the argument of this anid certioraxi was
granted, 34 U.S.L. Week 3294. (March 1, 1966) (No. 824).
— . .
5a
quirenients for testing and admini
The basic section of the Color Additive Amendments |
is § 706 of the Act, 21 U.S. CI § 376, which provides
that a,“color additive’? shall be deemed unsafe unless
it meets two conditions: The additive must be covered
by a „regulation,“ issued by.the Secretary on a find- .
wale * ing of suitability, which lists it for use either gen-
erally or under prescribed conditions; and it must
either come from a batch certified for such use by the
Secretary under appropriate regulations or have been
exempted from the certification requirement.
The term „color. additive,“ on which the controversy .
turns, is defined in 5 201 (t) (1), as a material which
(A) is a dye, pigment, or other substance made
-by a process of synthesis * * * or otherwise
derived * * * from a vegetable, animal, mineral,
or other source, and
(B) when added or applied. to a food, drug, or
cosmetic, or to the human body or any part
thereof, is capable (alone or through. reaction
—— * substance) of 8 color
3 ere
21 U.S.C. § 321(t) (1)
‘The Regulations of the Food and Drug Administration
(FDA) interpret the statutor definition of color
additive as oe “all diluents’’: and state further
5 oe A substance at, when applied to the human
body results in coloring, is a color additive,“
| — the function of coloring is purely inci-
„„ dental to its intended use, such as in the case of
5 deadorants. Lipstick, rouge, eye makeup
colors, and related cosmetics intended for
coloring the human body are “color additives.“
Reg. § 6.1(f).
This is subject to an exception, not heré important, for iin
additives covered by an exemption. for investigational use by
_— experts, 21 US. C. 8 376 0 (2) and (f). :
6a
4 The term “diluent” i is defined as:
any component of a color additive mixture that
is not of itself a color additive and has been
intentionally mixed therein to facilitate the
use of the in coloring. foods, drugs, or
cosmetics or in coloring the humay body. The
- _ .
—— RN re ee ee Uñ— — —— — . —Uä—
diluent may serve another functional purpose
in. the foods, drugs, or cosmeties, as for ex-
‘ample sw „ flavoring, emulsifying, or
stabilizing, or may be a functional component
of an article intended for coloring the human
Reg. § 8.1(m)
The manufacturers admit that the coloring 8 g
ent in a cosmetic is a lor. additive“ fully subject
to both listing and certification requirements ‘of § 706,
and that a diluent,“ in what they insist is the ac-
cepted definition of an inert substance used to dilute
. dyes and pigments, is subject to the Secretary’s. -
power to certify additives with safe diluents or with-
\ out diluents,” §706(c). . They complain, however,
5 the Regulations’ comprehensive. definition of
“eolor additive“ goes beyond the reach of the statute
in imposing both listidg ‘and certification require-
_ ments on finished products—like lipstick, nail polish,
eto. — and non-color ingredients that Were never in-
tended to be sjbject to premarketing clearance, and
on traditional diluents that were meant to be subject
only to certification as components: of - dyes: and
pigments.
The third count of the complaint abies to provi-
sions in the Regulations which attempt to subject hair
dye products to. p keting clearance in what is
alleged to be violation of the exemption recognized in
the statute. The Act as passed in 1938, in defining
“Sx ta .
a
cose cosmetics. that were deemed to be adulterated,
contained in §601(a) an explicit exemption for hair
This provision shall not apply to coal-tar hair
dye, the label of which bears the. following
legend conspicuously displayed thereon: “Cau-
tion—This product contains ingredients which
may cause skin irritation on certain individuals
and a preliminary test according to accompany-
ing directions shoufd first be made. This
. product must not be used for dyeing the) eye-
lashes or eyebrows; to do so many cause blind- 1
ness.“, and the labeling of which bears ade .
quate directions for such preliminary testing.
52 Stat. 1054 |
The exemption was carried forward in § 601(e) .
which declared that a cosmetic should be deemed
adulterated “If it is not a hair dye and it bears or
contains a coal-tar color other than one” from a certi-
fied hatch. When Congress revised the statute in the
1960 Amendments, it left §.601(a) as it was but modi-
fied § 601 (e) to read “If it is not a hair dye and it is,
or it bears or contains, a color additive which is un-
safe” within the meaning of § 706! a
The Regulations recognized the statutory exemp-
tion where proper labeling called for use of the patch
test but, armed with an expansive definition of “color
additive” in § 8.1 (f) which would on its face seem to
-include in a preparation for use on the hair any color-
ing ingredient as well as the finished product, pro-
ceeded to limit the exemption as follows:
The “‘hair dye” exemption in section 601 (a)
| of the act applies to those articles intended for
uses in altering’ the color of the hair and which
are, or which bear or contain, color additives
227-1816: ? n N
—
with the sensitization potentiol of causing skin
irritation, in certain individuals and possible
blindness when used for dyeing the eyelashes
or eyebrows. The exemption is permitted with
— condition — the label of any such article
9 1 —— y the statutory caution and |
* adequate ons for preliminary patch-test-
ing. If the poisonous or deleterious substance
in the “hair dye“ is one to which the caution
is inapplicable and for which patch-testing
provides no safeguard, the exemption does not
apply; nor does the exemption extend to poi-
~ sonous or deleterious diluents that may be in-
troduced as wetting agents, hair conditioners,
emulsifiers, or other components in a color
Shampoo, rinse, tint, or similar -dual-purpose
cosmeties that alter the color of the hair.
Reg. § 8(u)
The manufacturers claim that the Wan go
beyond the statute in several ways: Whereas the 1938
Act literally exempted from premarketing clearance
any coal-tar hair dye complying with the statutory —
condition of notice and the amendments did not pur-
port to effect any change, the Regulations grant ex-
emption only if the color additive in the hair dye sub-
stance is one whose irritating qualities would be de-
tected by a patch test; and, contrary to the longstand-.
ing interpretationin effect by regulation when the
amendments were adopted ‘—which applied the ex-
emption in its full scope to dual-purpose. hair prod-
nets like shampoos, rinses and tints with a coal-tar
coloring component, the Regulations seem to limit the
exemption to the coloring ingredient itself. 0
: + Reg. 8: 8 1.200 apparently defined the term “coal-tar hair dye”
im the §601(a) exemption to include “all articles containing
any coal-tar color.” This definition of hair dyes was déleted by
the Commissioner as superseded by § 8.1(u) of the Color Addi- -
3 28 F. R. 100688. (1988).
v /
Count 4 of the complaint attacks a section of the
Regulations, § 8.28(a)(4),. which states that wen
it appears to the Commissioner that a person has re-
fused to permit duly authorized employees of the
FDA “free access to all. manufacturing facilities,
. Processes, and formulae involved in the manufacture
pl eclor additives and intermediates from which such
oolor additives are derived,” he may suspend eertifi:
cation service to such person until adequate correc-
tive action is taken. The first sentence of .§ 704(a)
of the Aéff applicable to all goods, drugs, devices, or
cosmetics subject: thereto, authorizes the Secretary to
inspect any “factory, wareKouse, establishment, or
vehicle and all pertinent equipment, finished and un-
finished materials; containers, and labelling therein“;
the second sentence, dealing only with places where
prescription drugs are manufactured, processed or
held, provides for ‘inspection extending.“to all things
therein (including records, files, papers, processes,
controls, and facilities). The manufacturers say
the challenged regulation illegally extends to cos-
metics the broadened inspection authorized only for
Prescription drugs, and improperly subjects trade
“._.. seerets to exposure. . N 5
The expanded definition of color additives,” the
' narrowing of the hair dye exemption, and the al-
legedly compelled disclosure of ‘secret formulae and
processes impose, the manufacturers claim, burdens
not contemplated by the statute and. threaten. imme-
diate and irreparable injury. Even thoug}f coloring
ingredients have been properly pretested, listed: and
certified in compliance with the statutory clearance
8 scheme, the regulations require filing a separate list-
ing application for each finished produet, traditional
- diluent and non-eolor ingrédient, including those fot-
merly exempted under the hair. dye provision; each
1
tion; Reg. 5.8.51 (a). An affidavit * one —
N _ =
_ —
* 10
application must be accompanied by a $2,600. filing
fee, Reg. 5 8.50(c), and supported by extensive scien-
tific tests establishing suitability for intended use,
Reg. §8.4(c). Even after listing, every ingredient
and finished product: must come from a certified batch
unless the Secretary has granted an exemption; a
minimum fee of $100 is charged for each certifica-
turer claimed that the listing of its roduets
alone for' the issuance of regulations cn por 5
filing fees of $7,000,000: and testing costs of nearly
642,000 „000, and that certification fees for a single
year would unt to 750,000.“ Beyond such v
of-pocket. inereased hx substantial additional ex-
penses for record-keeping, compliance -with the chal-
lenged regulations, by requiring significant changes
in ‘established business practices and curtailing
distribution of new products, allegedly would cause
major and costly disruption of the cesmetic industry.
- Moreover, the disclosure of formulae and ‘processes
necessary to meet the new listing requirements and to
avoid loss of certification for refusing inspection
allegedly would result in misappropriation of trade
secrets and discourage research and development of
improved cosmetic products. !
Failure to comply with the challenged nen
could have serious consequences if they are valid.
Under § 601 of the Act, a cosmetic other than a hair
dye is deemed adulterated if. it is, or it bears or con-
tains, a color additive which is unsafe” within the
meaning, of §706(a). Projection-of any adulterated .
Very likely these figures are exaggerated since they take no:
account either of the FDA’s power to require information on
—— calla ot eeptig cheagntints wi.
AAG
. N *
8 ; ?
. injunction
and any adulterated article may be seized under §
under the statute, and are subject. te
entail criminal liability, §§ 301
ibited
The manufacturers say that, apart from all else, the-
publicity incident to criminal or civil proceedings
against them for failure to comply with the Regula- |
ay tions would be seriously detrimental in a highly com-
petitive industry which spends millions in cultivating
public good will and is dependent on: consumer confi-
dence in the integrity of its pr Muets.
The Secretary and the Commissioner respond that
the fears as to the dilemma posed by the tions *
are exaggerated. They insist that the N.
merely expound the manner in which they intend to
construe the. ents, that nothing has yet been
done to apply. provisions of which plaintiffs com-
plain, that ample opportunity to test the Regula- -
tions in. concrete fact situations is afforded by the
path for review spelled out in the statu If the
manufacturers will only comply with the li and
certification requirements, the FDA’s application of
the statute will, under §706(d), be subject to the
general administrative provisions on hearings and
review in § 701. Since the review authorized in
§706(d) is directed at decisions approving or dis-
’ approving listing and certification and §§ 701 (e) and
() are limited to review of other specifically enumer-
ated agency determinations, the contention is not that
the statutory provisions afford a direct path to review
of the regulations on listing requiréments;
it is 1 that furnish an indirect but neverthe-
less sufficient one ‘the manufacturers.ought to
~" have taken. The proper course, defendants say, is
for a manufacturer to petition for the listing of dilu-
122
ents and finished cosmetic products as color additives,
while protesting against the need for doing so and
conforming with the detailed requirements for filing
information only, to the extent he believes proper un-
der the statute; such a petition could be accompanied
by a request kor exemption from batch certification, .
again with appropriate protest and non-compliance
with the requirement of factual data to support the
application. Either the FDA would retreat from ap-
plying its announced interpretation of the statute and
grant the petition and the request for exemption, or
it would deny them. which event the road to a court
of appeals would be open under 55 701 (e) and (f).
ys 5 8 en
11 .
The serious — are whether direct challenge’
N ot the · Regulations by suit in a district court is im-
pliedly harred by the availability of review of listing
and certification denials in- a eourt of appeals, and
whether the controversy is appropriate for judicial
determination prior to application of ay Regulations
in a particular factual situation.
We are not persuaded that by providing a pro-
cedure fer review of certain administfative decisions
under the Food and Drug Act in the courts of appeals,
Congress meant to foreclose relief with respect to
have acted in excess of their authority an uncon-
We need not discuss in the text the surprising, contention
—— — _
senfed suit against the United States. The contrary\is clearly.
established by Philadelphia Co. v. Stimeon, 223 U.S. 606, 619-
20 (1912), see Stark v. Wickerd, 821 U.S. 288, 990 (1944), and
indeed follows i from Fe ports Young, 200 US. 128
(1908) ; law officers of Government ought not to take the
time of busy judges or of opposing parties by advancing an
argument 80 plainly foreclosed by Supreme Court decisions,
—
*.
0
other ageney action under the Administrative Pro-
18a
eedure Act 5 10, 5 U.S.C. § 1009, or the Declaratory
Judgement Act, 28. U. S. C. § 2201, in a ease where this
would otherwise be appropriate. The agency deter-
minations ‘specifically reviewable under § 701 (e) relate
to such technical subjects as chemical properties of
particular products and the formulation and appliea-
tion of safety standards for protecting public health;
in the to
substitution for any other rém provided by law.“
2
Congress naturally did not wis ceurts to consider
such matters without the benefit of the agency’s views
after an evidentiary hearing before it. Section 701,
however, also contemplated other less specialized ad-
ministrative action by authorizing, i in subsection (a),
the making of regulations for the efficient enforcement .
of the ry and it expressly declared. in subsection —
(f) that a provision for review of certain orders
of appeals was ip addition to and not in
21 U.S.. §371(£)(6): . The section as a whole does
not indicate to us any congressional intent either. to
insulate administrative action not covered by sub-
section (e) from challenge as in excess of statutory
authority, see Stark v: Wickard, 321 U.S. 288, 308-11
(1944); ef. Cappadora v. Celebrezze, 356 F. 2d 1, 5 „U:
. Cir. 1966), or to postpone immediate challenge to such
action where awaiting the issuances of adjudicative .
orders subject to statutory review would provide less
effective relief. Insofar as Abbott Labs. v. Cele-
The legislative history of the 1938 Act suggests that
gress had no intention of limiting teview of other action by
adopting a special procedure for the enumerated determinations. -
The House * referring to the savings clause in § 701
e tated :
There.is also wd a8 8 method to review a regulation
placed iat ger the Secretary whatever rights exist
tocinitiate a rica] proceeding in equity to enjoin the
a
—
14
brezze, 352 F. 2d 286, 289 (8 Cir. 1965), cert. granted,
. intimates otherwise, we are unwilling to follow it.
The question whether a plaintiff may obtain
judicial relief in cases like this has been variously -
. phrased as whether he has standing to challenge
- the administrative action as a person suffering legal
: ”* or “aggrieved’’ within the meaning of 5 10 of
the APA, whether the dispute is an actual contro-
versy within the. Declaratory Judgment Act, vr
whether it is sufficiently “‘ripe’’ for resolution by the
courts. See Jaffe, Judicial Control of Administra-
tive Action 395-98 (1965). In fact, the critical issue.
i sort of assistance on the
part of those subjected to such rules, see Columbia
United . 316 U.S.
a
——ů— — — — — —— tela — ——— p ARR Rh RE
15a
has gotten the slightest start.’ The problem i is not to
be solved, as the parties suggest, by applying some
readily procurable litmus paper which will determine
whetlier a controversy is justiciable“; what is re-
quired, as in the case of challenge to the constitution-
ality of a statute, is a reasoned evaluation of both
the appropriateness of the issues for decision by
courts and the hardship of denying judicial relief.
Joint. Anti-Fascist Refugee Comm. v. McGrath, 341
U.S. 123, 156 (1951) (Frankfurter, J., concurring); -
see q affe, supra, at 396, 423.
The appropriataness of passing judgment on the.
validity of an administrative regulation prior to its
application. to particualr facts depends on such fac-
tors as how far the rule represents the definitive posi-
tion of the agency. nd the extent to which thé
° ‘precision or scope. -Judicial determination might also
be deemed inappropriate where the controversy over
the rule did not present a legal issue that a court was
qualified to resolve without reference to factual de-
terminations more effectively made by the agency
familiar with day to day administration. See Jaffe,
supra, at 406. In this case, however, the Regulations
under attack were issued after a full hearing with
notice and by their terms represent the definitive
‘agency position on the reach of the statutory require-
ments for listing and certification of cosmetics, see
Columbia Broadcasting Sys., Inc. v., United States,
supra, 316 U.S. at 422; United States v. Storer Broad- -
casting Co., 351 U.S. 192, 198 (1956); to the extent
that they ‘purport. to apply premarketing require-
ments to broad categories like finished products —
and noncoloring ingredients and define the hair-dye
- exemption, they appear, prima facie, to be susceptible
of .reasoned comparison with the statutory mandate
without: inquiry into factual issues that ought to be
first véntilated before the agency. Indeed, it is mani-
fest that if the manufacturers adhere to their legal
position, pro forma, individual applications to the
FDA ‘for listing and certification would produce a
record no more, and very likely less, illuminating
than what the distriet court will develop at trial of
this action in which the great bulk of the industry
is represented and will be bound. The mere fact that
the procedure which the defendants suggest would
bring the issue directly to a court of appeals without
prior resort to a district court, while entitled to some
weight, is not controlling. As indicated earlier, the
statutory procedure for review of individual determi-
nations in the courts of appeals was not intended as
a means for challenging FDA rule-making of the
usual sort; as shown by the authorities discussed
below, the mere fact that pursuit of that course could
—— —— —
— a decision on legal i issues similar to _— here :
sought does not make its use mandatory
With respect to the other relevant 8 the
degree of hardship warranting declaratory relief,
although some older precedents suggest broadly that
an administrative ruling is not reviewable until and
unless it imposes an obligation or subjects the plain-
tiff to some civil or criminal liability, see, e. g., United
States v. Los Angeles & Salt Lake R. R., 273 U. S. 299,
309-10 (1927); Shannahan v. United States, 303 U. 8.
596, 599 (1938), there has been a growing recognition
that the timeliness of review depends on a broader
concept of the substantiality of present or immediate
harm. See 3 Davis, Administrative Law Treatise
_ § 2107 (1958). In Columbia Broadcasting Sys., Ino.
v. United States, 316 U.S. 407, 417-21 (1942), the
Supreme Court declared that. though a particular rule
does not of itself deny a license or directly impose
sanctions, | it may ‘nevertheless be reviewable if it
; establishes a general standard of conduct which by its
very promulgation demands conformity and poses, for
the plaintiff or others with whom ‘he must deal, the -
“alternatives of compliance or severe penalties of for-
feiture or disruption of business operations. In.
Frozen Food Express v. United States, 351 U. S. 40,
43.44 (1956), the Court recognized that an agéricy ©
order generally announcing the scope of administra- ~
tive regulation was subject to immediate frontal at-
tack, although opportunities for later challenge ‘were
sure to come from a-cease and desist order by the
ICC, see Eastern Texas Motor Lines v. Frozen Foo
“Express, 351 U.S. 49 (1956), or suit for an ‘injune-
tion by the agency or competitors.” And in United
If it be said that the carrier was subject, to liability for
criminal penalties even before a cease and desist order or ‘an
injunction, the same is true here, . - +
O N28
1
**
States v. Storer Broadcasting Co., 351 U. S. 192, 199-
200 (1956), declaratory rules setting limits on the
number of licenses to be granted for broadcasting sta-
tions under common ownership were held to be im-
mediately reviewable because they operated “to con-
trol the business affairs” of the plaintiff and made it
impossible to “cogently plan its present or future
operations” so long as their validity remained unde-
termined; direct challenge to the regulations. Was per-
mitted even though réview might have been obtained:
by provoking an adverse administrative order, see 351
U.S. at 208 (disse — opinion).” See also Flem-
‘ming v. Florida
* Eæch., 358 U.S. 153, 168
(1958).
We see little . in debating the point, much
discussed by the parties, whether the Regulations are
“interpretative” or legislative.“ Although that issue
V1 fact . FOC « dismissed the plaintiff's application for
an ad itions]-station on the basis of the new rules the very day
they were adopted, 351 U.S. at 197, but review of the par-
ticular decision Mus not. sought.
We recognize that in Storer review of the rule was in the
Court of Appeals for the District of Columbia, the same
tribuna] to which Storer would have gone for review of the
denial of an application; but the dissenters thought the ratich -
nl
lief in.a district court after the 60-day y Hendlition for, ek’
review by the Court of Appeals had expited, 351 8. 447210
((dissenting opinion of Hi J.). A more important differ-
entiating considtration may he that awaiting denial of a future
application may not have afforded a broadcaster who had
— epantieaib ainintniniabeaal sles — *
N b 19a |
would-have to be faced if the FDA had failed to com-
ply with the- rule-making procedures of $4 of the
APA because of a claim on its part that the Regula-
tions were merely “interpretative,” the interpretative
character of a regulation does not necessarily make it
unripe for review; we perceive no reason why a rule
whereby an agency subjects to regulation activities
contended. to be immune should be exempt from im-
mediate review becauge it purports to interpret t-
ute although it would not be if made in the exercise,
contended to be illegal, of a substantive rule-making
power. See Frozen Food Express v. United States,
supra; Jaffe, Judicial Control of Administrative Ac-
tion 405-07 (1965) ; and 1 Davis, Administrative Law
_ ‘Treatise § 5.03 (1965 Pocket Part), criticizing on this .
* . ground American President Lines, Ltd. v. FMC, 316
F. 2d 419 (D.C. Cir. 1963), on which defendants rely.
Neither do we think anything is to be gained by an
attempt at comprehensive review of · the decisions; the
many cases in this area are not truly reconcilable and
the law has been moving in the direction of greater
freedom of review, see Jaffe, supra, at 412-17 (which,
inter alia, eritieizes another decision relied on by de-
fendant, Heleo Prods. Co. v. McNutt, 137 F. 2d 681
(D.C. Cir. 1943)); and 3 Davis, Administrative Lax
Treatise §§ 21.06-21.08 (1958), We limit ourselves to
the two recent Court of Appeals decisions which ‘de-
. ... fendants most strongly urge upon us. 8
Danvuille Tobacco Ass’n v. Freeman, 351 F. 2d 832
(D.C. Cir, 1965), was a rather weak case for declara-
tory relief. ‘The plaintiffs there were neither threat- .
ened with penalties nor, like those in Frozen Food
and here, faced with the need of applying for licenses
to permit contirfiatida of an established business;
moreover, there: was no showing gliat the challenged
regulation was in fact preventing txpansion of their
of n N —
*
5
„the. i
a 1 : : 7 '
operations, since they had filed no applications aX”
petitions by other applicants had been denied on
© ‘grounds other than those attacked. Agreeing with the
defendants that Abbott Labs v. Celebrezze, 352 F. 2d
286 (3. Cir. 1965), cert. granted, is not distinguishable
on any satisfying basis, we must confess, with all re-
- spect, our inability to understand why the plaintiffs
there should be required to violate the challenged .
FDA regulation in order to raise the same legal issue
as to which the district court had granted declaratory
relief. Insofar as the Abbott decision rested on a neg-
tive implication from the limited -review provisions
‘Of the Food and Drug Act, we have we noted our
inability to 3 .
III.
In 8 the — considerations thus devel-
oped to · the previse issues here presented, we must _
bear ingnind that this appeal is not from a declara
tory. ju t but from the denial of a motion to dis- =
miss a complaint seeking oné. The issue on such an-
appeal is not whether the grant of a declaratory |
Judgment was in faet appropriate but whether it so
clearly would not be that dismissal in limine was re
— quired:
the counts of the e —
usion of ed products and color additives
and the alleged ctions of the hair-dye exemption, —
the appeal must fail, These Regulations appear to -
have an immediate impact on the industry, posing the
unacceptable alternatives of complying or of. incur-
ring possible forfeitures: and criminal liability, and N
Calling into question long standing practices of pre- ö 3
marketing testing and clearance. The issues framed
by the counts of the complaint addressed to these
ean — ä suitable for immedi-
*
21a 2
ate judicial resolution and the threatened harm suf.
ficiently great, that the district court properly ge"
elined to dismiss them. If the court should find 1
the issues are not susceptible of resolution without
detailed factual evidence that ought to be first sifted
by the agency, or that measures being taken by the
_ FDA for the listing and exemption from certification
of approval diluents have so reduced the hardship on
the plaintiffs as to make declaratory relief inappro-
Priate, it need not proceed to judgment. But, so far
as we can now see, the souner the industry's claims
as to the coverage of the Act in these respeets are de-
termined, the better for everybody. As said in Jaffe,
Judicial Review of Administrative Action 404 (1965),
“The public has an intérest in early implementation
of policy ; the regulated person has a legitimate inter-
est whether to plan or not to plan his operation.”
Moreover, the party disappointed by court decision
may wish to take the case to Congress. . |
. e fourth count of the complaint, relating to
agency inspection of formulae and processes, stands
differently. Here the challenged regulation, 68.28 (a)
(4), does not of itself demand compliance at the ex-
pense of penalties. A manufacturer who refuses ac-
cess to his trade secrets is not threatened with crim-
' inal liability or seizure; the regulation does not sug-
gest that such refusal will be deemed za “prohibited
act” under the statute, as it would be in the case of
prescription drugs. It simply warns the industry that
the Commissioner may—not that he inevitably will .
consider a refusal to permit such inspection a suffi-
cient cause for suspending certification. Moreover,
the next paragraph 88.29 (b), says that upon receipt
of notice of suspension, the person so notified may re-
quest a hearing upon the factual basis therefor. If -
after such: hearing the Commissionemshould adhere to
‘ * 8
1 ö . : *
0 0 ‘ * b
. a
8 *
8 I K % % · ·· / % ee a ee
his refusal to certify, M ee g
would seem available under §§706(d) and 701 (f); if
not, an action could be brought in the district court.
II this instance the possibility of unlawful - injury
to the plaintiffs is, on its face, too remote for declara- | .
tory relief. No one can nod say whether the Commis
sioner will ever make a demand for free access to
color additive processes or formulae, whether any
manufacturer will ever decline this, What the Com-
ii would do if so refused, and what result a
hearth would have. The fact that the Commission-
er’s proclamation , of the possible consequences of re-
fusal may induce manufacturers to be more mpliant |
than if he liad kept silent until an episode for
action.arose is riot a sufficient basis for declaratory
Belief. Moreover, it Ts impossible to see what declara-
tion a court could properly make. No one could rea-
sonably assert that circumstances warranting suspen-
sion of certification if a manufacturer refused to give :
the FDA information concerning processes. or for-
mulae could never arise; Congress failure to empower
the ageney to compel an inspection of processes of... -
formulae is not a mandate to grant certificates when
the publie cannot properly be protected otherwise.
Revitw of this Regulation should be on a case by case
- basis and with a factual record to assist in determin-
ing whether access to secret processes and formulae is
necessary and appropriate to performance of the tak
of effective premarketing elearance in a particular
instance—at least in the absence of experience *
ing consistent abusive tactiess. ö
The judgment with respect to Count 4 is reversed .
with i ions to grani the motion to dismiss; the
judgm ith respect to Counts 1, 2, and 3 is af
8 firmed, with further proceedings to be promptly taken
t in the district court in accordance with this opinion.
0
ArrN¹⁴ NB
Vi JUDGMENT OF THE CoURT oF APPEALS
Wetec SN For THE SH Crrcurr
*
At @ Stated Term of the United Btates Court of
Appeals, in and for the Sécond Circuit, held at the
United States Courthousé in the City of New York,
on the thirteenth day of April one thousand nine hun-
- dred and sixty-six. | N
Present: Hon. Sterry R. Waterman, Hon. Leonard
e. P. Moore, Hon. Henry J. Friendly, Cireuit Judges.
Tun Toner Goons AssoclaTION, INC., Er Al.,
AntHony J. Cerkerezze, SzcreTary oF HEALTH, Eb o-
mon AND WELFARE, AND GEoRGE P. Larniox, Com-
,MIISSIONER OF Foop aNnD DRuds, DEFENDANTS-
ee : (er. . 8
Appeal from the United States Distriet Court for
the Southern District of New York. a
This cause came on to be heard on the transcript of
record from the United States District Court for the
Southern District of New York, and was argued by
ON CONSIDERATION WHEREOF, it, is now -
hereby ordered, adjudged, and decreed that the order
of said Distriet Court be and it hereby is affirmed as
to the First, Second and Third Counts of the complaint.
oy, 3 3 5
It is further ordered that the order of said District
; Court be and it hereby is reversed as to the Fourth
Count of the complaint with instructiens to grant the
this court.
5 1 DANIEL Pusano,,
_ Clerk.
5
J
* 7
—
5 5
0
nal a 1 + e
* ° 1 \
g *
. « 0
2 “ae, N
—
mee =
e es,
. * - 9
J ine *
‘ —
* “a
‘ — . : *
i * — — 55
ear 3
eo —
—
. °
*
* bad 2 .
-
0 4 22
~ — 0
* . *
8
a ~
8 —
* ot
. 2 ° 7
* 7 —
„ 0 :
i ° .
4
3 4 .
7 e < 5 8
>. RA ere . 1 — es oe . oe “
— — — — — — — — — 22
° < rte — — — — oom,
Pers aie res ata
2
motion to dismiss in aceordanee with the of
2
=
*
*
8 — — —_— ee —
. ‘. N
part:
e
1
1. The Federal Deeclaratory J ulgment Le 20 28
0 1 O. 2201, provides, in pertinent part;
Creation of remedy
In a case of actual controversy within its
jurisdiction, except witk respect to Federal
— ry" court of the United States, upon the
ling of an appropriate. pleading, may declare
= rights = ae legal relations: of any in-
terested rtx seeking such declaration,
whether or 3 further relief is or — be
sought. * * # 8
Section 10 of the Administrative — A
60 Stat. 243, 5 U.S.C. 1009, * in **
Exedpt 80 a as a) a statutes. 1 judicial
review or (2) ageney action is by law: ‘committed.
to agency -discretion—
(a) Rieut or Review.—Any person’ siiffer- |
ing legal wrong because of any agency action,
or adversely affected or aggrieved by such ac-
tion, within the of any relevant — -
hall be entitled to ju * review thereof.
— AND VENUE oF Acrion.—The form 5
of probeeding for judicial review shall be any
pedal statutory review proceeding 8 to
„AI the subject matter im aby court specified by
v
__ statute or, in the absenée or inadequacy nee
any applicable form of legal action (ineludi
. . actions for declaratory judgmerits or writs o
Prchibitary or mandatory injunction or 4
eorpus) in any court of competent jurisdi
aaa * action shall be e to. iia ne
(ia)
i
4
26a
view in’ civil or criminal proceedings for jndi-
cial enforcement except to the extent that prior,’
adequate, and exclusive opportunity for — .
review is provided by law. 28
(e) REVIEWABLE —Every agency. action
made reviewable by statuts and every: final!
agency action for which there is no other ade-
quate remedy in any court shall be subject to A
„Judicial review. Any preliminary, procedural,
— intermediate ageney action or ruling not di-
reetly reviewable shall be subject to review
4 upon the review of the final ageney action. Ex-
L cept as otherwise expressly required by statute,
+ agency action duties shall be final for
the purposes of this subsection: whether’ or not
there has been presented or determined any ap-
plication for a declaratory order, for any form
‘ z reconsideration, or (unless the agency other ö
N wise requires by rule and p rovides that the a“-Ub
8 tion meanwhile shall be in — for an
8 appeal to superior agency a ;
: . Section 201 (t) (1) of the 1960 “Drug Additive
amendments to the Federal Food; Drug and Cos.
metic Act, 74 Stat. 397, 21 U.S. C. * prom OK
- Vides: ‘3
7 The term “eolor additive” means a material
98 is a dye, nt, or other substance
8 by a process of synthesis or si =
hee, or extracted, isolated, or othe Se eee
— with or without intermediate or ‘nal . ,
of identity, from 4 —— ne
or other source, * = ie
0 When added or 2 to a f
a ek Ce e ede 3
8 thereof, is. ca (alone or through 4 a
‘ei other ). of: imparting color
2 except ‘ha auch n does not iniude any
8 material W the 9 hy —
pstick, rouge, eye makeup colors, and re-
0 8
serve aother functional purpose in the foods,
‘drugs, or cosmetics, as for. example sweetening,
flavoring, emulsifying, or stabilizing, or. may be
a functional, component of an article intended
for coloring the human body. U *
21 C. F. R. 8.1 (u) provides: . a
The “hair dye’? exemption in section 601 (a)
of the act applies to those axticles intended for
use in “altering the color of the hair and which
gare, or which bear or contain, color additives
With the sensitization protential of causing skin
irritation in certain individuals and possible
blindness when used for dyeing the eyelashes |
or eyebrows. The exemption is permitted wit
the condition that the label of any such artiele
bear conspicuously. the statutory caution: and
- adequate ‘directions for preliminary patch-
— in the “hair dye“ is one to which the
caution is. inapplicable and for which. patch-
testing provides no safeguard, the exeniption
does not apply; nor does the exemption extend
to poisonous or deleterious diluents that may be
introduced as wetting agents, hair conditioners, .
. emulsifiers, or other components in a color sham-
rinse, tint, or similar dual-purposé cos-
, a that alter the color of the hair.
21 CFR. 8.28(a) (4). provides:
(a) When it appears to the Cohianiasioner
that a N has:
* 5 22 & * A vay ee
(4) ‘Refused to permit duly authorized em- 8
be of the Food and Drug Administration
access to all manufacturing facilities, proc-
and formulae involved in the manufac-
ture of color additives and intermediates from
which such color additives are derived; he may
immediately suspend certification service to
such n and may continue. Bes suspension
until * ä action been taken.
a ee, d K *
1 we 4 :
« ° 2 —
2.8. GOVERNMENT PRINTING OFFICE: 1966
—— —— —— in NB RN ont —ꝓ — —
2
Also, similar questions of “ripeness” and “justiciabil-
ity’? are involved in Abbott Laboratories v. Gardner,
in which this Court has granted certiorari, 383 U.S.
924, No. 39, this Term. In these circumstances,
while we believe that the court of appeals rendered
the correct decision on the question ‘presented by the
instant petition, we agree that it would be appro-
priate either to defer consideration of this petition /
until after the decision in Abbott Laboratories v.
Gardner. or to grant this petition and our cross-peti-
tion so that the Court may consider the issues pre-
sented in the Farying factual contexts.
sepia submitted. * 9 1
T Un0O00 MARSHALL,
. } . Solicitor General.
Aveust 1966. L ö
— Thbe challenged regulafjon provides that the Food and —_— ä — —
Commissioner may imm ly suspend certification service ~
of a color additive when the manufacturer has “[rJefused to
permit duly authorized employees of the Food and Drug
Administration free access to all manufacturing facilities,
processes, and formulae involved in the manufacturer of color
additives and intermediates from which such color additives
are derived” (21 C. F. R. 828 (4)). The court of appeals held
that review was premature since the regulation “simply warns
the industry that the Commissioner may—not that he inevit-
ably will — consider a refusal to permit such inspection a
sufficient cause for suspending certification” (360 F. 2d at 687)
And since a companion regulation (21 C.F.R. 8.28 (b)) provides
for an administrative hearing on the propriety of the withdrawal
’ of certification. Review may presumably be had in the court of
appeals if the commissioner were to insist upon withdrawing e
8 nn (Pet. App. A, pp. 1-21). ; 8
*
U.S. GOVERNMENT PRINTING OFFICE: 1906
* 4 1
o
— 9
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.